PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease-Reference-Cited by-同舟云学术

PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease

Published:2023-11-13 Issue:1 Volume:20 Page:
ISSN:2049-9434
Container-title:Biomedical Reports
language:
Short-container-title:Biomed Rep

Author:

Honda Takuya¹,Ichikawa Tatsuki²,Yamashima Mio²,Yamamichi Shinobu²,Koike Makiko³,Nakano Yusuke³,Honda Tetsurou²,Yajima Hiroyuki²,Miyazaki Osamu²,Kuribayashi Yasutaka²,Ikeda Tomonari²,Okamura Takuma²,Nagata Kazuyoshi²,Nakao Kazuhiko⁴

Affiliation:

1. Clinical Oncology Center, Nagasaki University Hospital, Nagasaki 852‑8501, Japan

2. Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850‑8555, Japan

3. Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Nagasaki 850‑8555, Japan

4. Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852‑8501, Japan

Publisher

Spandidos Publications

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference49 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

3. Different characteristics of serum alfa fetoprotein and serum des-gamma-carboxy prothrombin in resected hepatocellular carcinoma;Hayashi;In Vivo,2021

4. Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma;Taura;Med Sci Monit,2013

5. Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma;Tameda;Cancer Sci,2013